{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:45:17Z","timestamp":1791985517167,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30-AI073961"],"award-info":[{"award-number":["P30-AI073961"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State of Florida HIV Reservoirs Pilot","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int.J. Behav. Med."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12529-019-09804-4","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T15:02:45Z","timestamp":1563289365000},"page":"542-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Post-traumatic Stress Disorder, Cocaine Use, and HIV Persistence"],"prefix":"10.1007","volume":"26","author":[{"given":"Olorunleke","family":"Oni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danita","family":"Jemison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8146-5701","authenticated-orcid":false,"given":"Adam W.","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"8","key":"9804_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10461-011-0127-4","volume":"16","author":"EL Machtinger","year":"2012","unstructured":"Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16(8):2091\u2013100. \nhttps:\/\/doi.org\/10.1007\/s10461-011-0127-4\n\n.","journal-title":"AIDS Behav"},{"issue":"11","key":"9804_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1176\/appi.ajp.2007.06111775","volume":"164","author":"J Leserman","year":"2007","unstructured":"Leserman J, Pence BW, Whetten K, et al. Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry. 2007;164(11):1707\u201313. \nhttps:\/\/doi.org\/10.1176\/appi.ajp.2007.06111775\n\n.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"9804_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/09540120600774230","volume":"19","author":"DM Israelski","year":"2007","unstructured":"Israelski DM, Prentiss DE, Lubega S, Balmas G, Garcia P, Muhammad M, et al. Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV\/AIDS. AIDS Care. 2007;19(2):220\u20135. \nhttps:\/\/doi.org\/10.1080\/09540120600774230\n\n.","journal-title":"AIDS Care"},{"issue":"8","key":"9804_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archpsyc.58.8.721","volume":"58","author":"EG Bing","year":"2001","unstructured":"Bing EG, Burnam M, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus\u2013infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721\u20138. \nhttps:\/\/doi.org\/10.1001\/archpsyc.58.8.721\n\n.","journal-title":"Arch Gen Psychiatry"},{"key":"9804_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.drugalcdep.2016.10.002","volume":"169","author":"KE Gamarel","year":"2016","unstructured":"Gamarel KE, Brown L, Kahler CW, Fernandez MI, Bruce D, Nichols S. Prevalence and correlates of substance use among youth living with HIV in clinical settings. Drug Alcohol Depend. 2016;169:11\u20138. \nhttps:\/\/doi.org\/10.1016\/j.drugalcdep.2016.10.002\n\n.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"9804_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","volume":"111","author":"TB Baker","year":"2004","unstructured":"Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33\u201351. \nhttps:\/\/doi.org\/10.1037\/0033-295X.111.1.33\n\n.","journal-title":"Psychol Rev"},{"issue":"10","key":"9804_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archpsyc.55.10.913","volume":"55","author":"HD Chilcoat","year":"1998","unstructured":"Chilcoat HD, Breslau N. Posttraumatic stress disorder and drug disorders: testing causal pathways. Arch Gen Psychiatry. 1998;55(10):913\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"9804_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/10550490050172227","volume":"9","author":"S Back","year":"2000","unstructured":"Back S, Dansky BS, Coffey SF, Saladin ME, Sonne S, Brady KT. Cocaine dependence with and without post-traumatic stress disorder: a comparison of substance use, trauma history and psychiatric comorbidity. Am J Addict. 2000;9(1):51\u201362.","journal-title":"Am J Addict"},{"issue":"2","key":"9804_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/ajp.155.2.214","volume":"155","author":"LM Najavits","year":"1998","unstructured":"Najavits LM, Gastfriend DR, Barber JP, Reif S, Muenz LR, Blaine J, et al. Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Am J Psychiatry. 1998;155(2):214\u20139. \nhttps:\/\/doi.org\/10.1176\/ajp.155.2.214\n\n.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"9804_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0306-4603(95)00024-7","volume":"20","author":"ME Saladin","year":"1995","unstructured":"Saladin ME, Brady KT, Dansky BS, Kilpatrick DG. Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations. Addict Behav. 1995;20(5):643\u201355.","journal-title":"Addict Behav"},{"key":"9804_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2015_440","volume":"389","author":"D Looney","year":"2015","unstructured":"Looney D, Ma A, Johns S. HIV therapy-the state of art. Curr Top Microbiol Immunol. 2015;389:1\u201329. \nhttps:\/\/doi.org\/10.1007\/82_2015_440\n\n.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"9804_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7326\/M17-2242","volume":"169","author":"RM Nance","year":"2018","unstructured":"Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, et al. HIV viral suppression trends over time among HIV-infected patients receiving Care in the United States, 1997 to 2015: a cohort study. Ann Intern Med. 2018;169(6):376\u201384. \nhttps:\/\/doi.org\/10.7326\/M17-2242\n\n.","journal-title":"Ann Intern Med"},{"key":"9804_CR13","doi-asserted-by":"crossref","unstructured":"Carrico AW, Hunt PW, Neilands TB, et al. Stimulant use and viral suppression in the era of universal antiretroviral therapy. J Acquir Immune Defic Syndr. in press;80(1):89\u201393.","DOI":"10.1097\/QAI.0000000000001867"},{"issue":"10","key":"9804_CR14","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/QAD.0b013e328353f3f1","volume":"26","author":"TW Chun","year":"2012","unstructured":"Chun TW, Fauci AS. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure. AIDS (London, England). 2012;26(10):1261\u20138. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e328353f3f1\n\n.","journal-title":"AIDS (London, England)"},{"issue":"6","key":"9804_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ni.3152","volume":"16","author":"TW Chun","year":"2015","unstructured":"Chun TW, Moir S, Fauci AS. HIV reservoirs as obstacles and opportunities for an HIV cure. Nat Immunol. 2015;16(6):584\u20139. \nhttps:\/\/doi.org\/10.1038\/ni.3152\n\n.","journal-title":"Nat Immunol"},{"key":"9804_CR16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/487439a","volume":"487","author":"SG Deeks","year":"2012","unstructured":"Deeks SG. Shock and kill. Nature. 2012;487:439\u201340. \nhttps:\/\/doi.org\/10.1038\/487439a\n\n.","journal-title":"Nature."},{"issue":"8","key":"9804_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3262","volume":"12","author":"SG Deeks","year":"2012","unstructured":"International ASSWGoHIVC, Deeks SG, Autran B, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12(8):607\u201314. \nhttps:\/\/doi.org\/10.1038\/nri3262\n\n.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9804_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","volume":"10","author":"R Fromentin","year":"2019","unstructured":"Fromentin R, DaFonseca S, Costiniuk CT, el-Far M, Procopio FA, Hecht FM, et al. PD-1 blockade potentiates HIV latency reversal ex vivo in CD4(+) T cells from ART-suppressed individuals. Nat Commun. 2019;10(1):814. \nhttps:\/\/doi.org\/10.1038\/s41467-019-08798-7\n\n.","journal-title":"Nat Commun"},{"issue":"3","key":"9804_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DIS, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 2013;155(3):540\u201351. \nhttps:\/\/doi.org\/10.1016\/j.cell.2013.09.020\n\n.","journal-title":"Cell."},{"issue":"2","key":"9804_CR20","doi-asserted-by":"publisher","first-page":"e1003174","DOI":"10.1371\/journal.ppat.1003174","volume":"9","author":"S Eriksson","year":"2013","unstructured":"Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013;9(2):e1003174. \nhttps:\/\/doi.org\/10.1371\/journal.ppat.1003174\n\n.","journal-title":"PLoS Pathog"},{"issue":"8","key":"9804_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15(8):893\u2013900. \nhttps:\/\/doi.org\/10.1038\/nm.1972\n\n.","journal-title":"Nat Med"},{"issue":"7","key":"9804_CR22","doi-asserted-by":"publisher","first-page":"e70164","DOI":"10.1371\/journal.pone.0070164","volume":"8","author":"VG Valcour","year":"2013","unstructured":"Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, et al. HIV DNA reservoir increases risk for cognitive disorders in cART-naive patients. PLoS One. 2013;8(7):e70164. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0070164\n\n.","journal-title":"PLoS One"},{"key":"9804_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12977-018-0397-2","volume":"15","author":"AO Pasternak","year":"2018","unstructured":"Pasternak AO, Berkhout B. What do we measure when we measure cell-associated HIV RNA. Retrovirology. 2018;15:13. \nhttps:\/\/doi.org\/10.1186\/s12977-018-0397-2\n\n.","journal-title":"Retrovirology."},{"issue":"1","key":"9804_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-4690-10-41","volume":"10","author":"AO Pasternak","year":"2013","unstructured":"Pasternak AO, Lukashov VV, Berkhout B. Cell-associated HIV RNA: a dynamic biomarker of viral persistence. Retrovirology. 2013;10(1):41. \nhttps:\/\/doi.org\/10.1186\/1742-4690-10-41\n\n.","journal-title":"Retrovirology."},{"issue":"5","key":"9804_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/PSY.0b013e3181777a5f","volume":"70","author":"J Leserman","year":"2008","unstructured":"Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539\u201345. \nhttps:\/\/doi.org\/10.1097\/PSY.0b013e3181777a5f\n\n.","journal-title":"Psychosom Med"},{"issue":"21","key":"9804_CR26","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.lfs.2010.10.002","volume":"88","author":"AW Carrico","year":"2011","unstructured":"Carrico AW. Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV. Life Sci. 2011;88(21):940\u20137. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2010.10.002\n\n.","journal-title":"Life Sci"},{"issue":"11","key":"9804_CR27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/QAD.0b013e32830507f2","volume":"22","author":"JA Cook","year":"2008","unstructured":"Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS. 2008;22(11):1355\u201363. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e32830507f2\n\n.","journal-title":"AIDS."},{"issue":"5","key":"9804_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/QAI.0000000000000364","volume":"67","author":"AW Carrico","year":"2014","unstructured":"Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, et al. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2014;67(5):508\u201313. \nhttps:\/\/doi.org\/10.1097\/QAI.0000000000000364\n\n.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"9804_CR29","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0006-3223(99)00219-X","volume":"46","author":"SM Southwick","year":"1999","unstructured":"Southwick SM, Bremner JD, Rasmusson A, Morgan CA 3rd, Arnsten A, Charney DS. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry. 1999;46(9):1192\u2013204.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"9804_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0306-4530(87)90017-5","volume":"12","author":"TR Kosten","year":"1987","unstructured":"Kosten TR, Mason JW, Giller EL, Ostroff RB, Harkness L. Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder. Psychoneuroendocrinology. 1987;12(1):13\u201320.","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"9804_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00005053-199205000-00006","volume":"180","author":"R Yehuda","year":"1992","unstructured":"Yehuda R, Southwick S, Giller EL, Ma X, Mason JW. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis. 1992;180(5):321\u20135.","journal-title":"J Nerv Ment Dis"},{"issue":"8","key":"9804_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s10461-014-0877-x","volume":"19","author":"G Ironson","year":"2015","unstructured":"Ironson G, O'Cleirigh C, Kumar M, et al. Psychosocial and neurohormonal predictors of HIV disease progression (CD4 cells and viral load): a 4 year prospective study. AIDS Behav. 2015;19(8):1388\u201397. \nhttps:\/\/doi.org\/10.1007\/s10461-014-0877-x\n\n.","journal-title":"AIDS Behav"},{"issue":"9","key":"9804_CR33","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1128\/JVI.80.9.4326-4335.2006","volume":"80","author":"EK Sloan","year":"2006","unstructured":"Sloan EK, Tarara RP, Capitanio JP, Cole SW. Enhanced replication of simian immunodeficiency virus adjacent to catecholaminergic varicosities in primate lymph nodes. J Virol. 2006;80(9):4326\u201335. \nhttps:\/\/doi.org\/10.1128\/JVI.80.9.4326-4335.2006\n\n.","journal-title":"J Virol"},{"key":"9804_CR34","volume-title":"Stress increases HIV transcription in HIV-infected individuals on antiretroviral therapy: implications for biomarkers of HIV persistence","author":"RMP Hecht","year":"2017","unstructured":"Hecht RMP, Mendes W, Cockerham L, Hartogenesis W, Bacchetti P, Chang J, et al. Stress increases HIV transcription in HIV-infected individuals on antiretroviral therapy: implications for biomarkers of HIV persistence. Paris, France: 9th IAS conference on HIV science; 2017."},{"issue":"4","key":"9804_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.4A0714-356R","volume":"97","author":"AB Addai","year":"2015","unstructured":"Addai AB, Pandhare J, Paromov V, Mantri CK, Pratap S, Dash C. Cocaine modulates HIV-1 integration in primary CD4(+) T cells: implications in HIV-1 pathogenesis in drug-abusing patients. J Leukoc Biol. 2015;97(4):779\u201390. \nhttps:\/\/doi.org\/10.1189\/jlb.4A0714-356R\n\n.","journal-title":"J Leukoc Biol"},{"key":"9804_CR36","doi-asserted-by":"publisher","first-page":"13179","DOI":"10.1038\/srep13179","volume":"5","author":"M Massanella","year":"2015","unstructured":"Massanella M, Gianella S, Schrier R, Dan JM, P\u00e9rez-Santiago J, Oliveira MF, et al. Methamphetamine use in HIV-infected individuals affects T-cell function and viral outcome during suppressive antiretroviral therapy. Sci Rep. 2015;5:13179. \nhttps:\/\/doi.org\/10.1038\/srep13179\n\n.","journal-title":"Sci Rep"},{"issue":"6","key":"9804_CR37","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/QAD.0000000000001751","volume":"32","author":"AW Carrico","year":"2018","unstructured":"Carrico AW, Cherenack EM, Roach ME, Riley ED, Oni O, Dilworth SE, et al. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS. 2018;32(6):767\u201371. \nhttps:\/\/doi.org\/10.1097\/QAD.0000000000001751\n\n.","journal-title":"AIDS."},{"key":"9804_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbi.2018.04.004","volume":"71","author":"AW Carrico","year":"2018","unstructured":"Carrico AW, Flentje A, Kober K, Lee S, Hunt P, Riley ED, et al. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun. 2018;71:108\u201315. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2018.04.004\n\n.","journal-title":"Brain Behav Immun"},{"key":"9804_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11481-018-9797-2","volume":"14","author":"K Grosgebauer","year":"2018","unstructured":"Grosgebauer K, Salinas J, Sharkey M, Roach M, Pallikkuth S, Dilworth SE, et al. Psychosocial correlates of monocyte activation and HIV persistence in methamphetamine users. J NeuroImmune Pharmacol. 2018;14:16\u201322. \nhttps:\/\/doi.org\/10.1007\/s11481-018-9797-2\n\n.","journal-title":"J NeuroImmune Pharmacol"},{"key":"9804_CR40","unstructured":"Weathers FW, Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., & Schnurr, P.P. (2013). The PTSD checklist for DSM-5 (PCL-5). 2013. The National Center for PTSD at \nwww.ptsd.va.gov\n\n. Accessed 13 July 2019."},{"key":"9804_CR41","unstructured":"Alere iCup Drug Screen. \nhttps:\/\/www.alere.com\/en\/home\/product-details\/icup-a-d-drug-screen.html\n\n. Accessed 13 July 2019."},{"issue":"3","key":"9804_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09595230500170266","volume":"24","author":"DAL Newcombe","year":"2005","unstructured":"Newcombe DAL, Humeniuk RE, Ali R. Validation of the World Health Organization alcohol, smoking and substance involvement screening test (ASSIST): report of results from the Australian site. Drug and Alcohol Review. 2005;24(3):217\u201326. \nhttps:\/\/doi.org\/10.1080\/09595230500170266\n\n.","journal-title":"Drug and Alcohol Review"},{"key":"9804_CR43","unstructured":"Ali RHR. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and Pilot Brief Intervention: a technical report of phase II findings of the WHO ASSIST Project. 2006."},{"issue":"2","key":"9804_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1310\/JFXH-G3X2-EYM6-D6UG","volume":"5","author":"TP Giordano","year":"2004","unstructured":"Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials. 2004;5(2):74\u20139. \nhttps:\/\/doi.org\/10.1310\/JFXH-G3X2-EYM6-D6UG\n\n.","journal-title":"HIV Clinical Trials"},{"issue":"6","key":"9804_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1545109709352884","volume":"8","author":"A Simple Single Item Rating Scale to Measure Medication","year":"2009","unstructured":"A Simple Single Item Rating Scale to Measure Medication. Adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chicago, Ill : 2002). 2009;8(6):367\u201374. \nhttps:\/\/doi.org\/10.1177\/1545109709352884\n\n.","journal-title":"J Int Assoc Physicians AIDS Care (Chicago, Ill : 2002)"},{"issue":"2","key":"9804_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","volume":"62","author":"AC Justice","year":"2013","unstructured":"Justice AC, Modur SP, Tate JP, Althoff KN, Jacobson LP, Gebo KA, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (1999). 2013;62(2):149\u201363. \nhttps:\/\/doi.org\/10.1097\/QAI.0b013e31827df36c\n\n.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"4","key":"9804_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","volume":"27","author":"JP Tate","year":"2013","unstructured":"Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS (London, England). 2013;27(4):563\u201372. \nhttps:\/\/doi.org\/10.1097\/QAD.0b013e32835b8c7f\n\n.","journal-title":"AIDS (London, England)"},{"issue":"2","key":"9804_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/09540120410001641084","volume":"16","author":"DL Delahanty","year":"2004","unstructured":"Delahanty DL, Bogart LM, Figler JL. Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals. AIDS Care. 2004;16(2):247\u201360. \nhttps:\/\/doi.org\/10.1080\/09540120410001641084\n\n.","journal-title":"AIDS Care"},{"key":"9804_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-med-052716-031710","volume":"69","author":"AM Spivak","year":"2018","unstructured":"Spivak AM, Planelles V. Novel latency reversal agents for HIV-1 cure. Annu Rev Med. 2018;69:421\u201336. \nhttps:\/\/doi.org\/10.1146\/annurev-med-052716-031710\n\n.","journal-title":"Annu Rev Med"},{"issue":"12","key":"9804_CR50","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1086\/379894","volume":"188","author":"RJ Ellis","year":"2003","unstructured":"Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S, Grant I, et al. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis. 2003;188(12):1820\u20136. \nhttps:\/\/doi.org\/10.1086\/379894\n\n.","journal-title":"J Infect Dis"},{"issue":"8","key":"9804_CR51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/PSY.0b013e318157b142","volume":"69","author":"AW Carrico","year":"2007","unstructured":"Carrico AW, Johnson MO, Moskowitz JT, Neilands TB, Morin SF, Charlebois ED, et al. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy. Psychosom Med. 2007;69(8):785\u201392. \nhttps:\/\/doi.org\/10.1097\/PSY.0b013e318157b142\n\n.","journal-title":"Psychosom Med"},{"issue":"1","key":"9804_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcv.2011.09.018","volume":"53","author":"MR Boulassel","year":"2012","unstructured":"Boulassel MR, Chomont N, Pai NP, Gilmore N, Sekaly RP, Routy JP. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53(1):29\u201332. \nhttps:\/\/doi.org\/10.1016\/j.jcv.2011.09.018\n\n.","journal-title":"J Clin Virol"},{"issue":"1","key":"9804_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/COH.0000000000000122","volume":"10","author":"J Ananworanich","year":"2015","unstructured":"Ananworanich J, Dub\u00e9 K, Chomont N. How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? Curr Opin HIV AIDS. 2015;10(1):18\u201328. \nhttps:\/\/doi.org\/10.1097\/COH.0000000000000122\n\n.","journal-title":"Curr Opin HIV AIDS"}],"container-title":["International Journal of Behavioral Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12529-019-09804-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12529-019-09804-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12529-019-09804-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T15:53:21Z","timestamp":1601394801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12529-019-09804-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["9804"],"URL":"https:\/\/doi.org\/10.1007\/s12529-019-09804-4","relation":{},"ISSN":["1070-5503","1532-7558"],"issn-type":[{"value":"1070-5503","type":"print"},{"value":"1532-7558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"16 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all participants in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}